Eton Pharmaceuticals, Inc. (ETON) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$4.60M | -20.4% |
| 2024 | -$3.82M | -308.4% |
| 2023 | -$936.0K | +89.6% |
| 2022 | -$9.02M | -361.4% |
| 2021 | -$1.96M | +93.0% |
| 2020 | -$27.97M | -52.7% |
| 2019 | -$18.32M | -43.8% |
| 2018 | -$12.74M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$4.60M | -20.4% |
| 2024 | -$3.82M | -308.4% |
| 2023 | -$936.0K | +89.6% |
| 2022 | -$9.02M | -361.4% |
| 2021 | -$1.96M | +93.0% |
| 2020 | -$27.97M | -52.7% |
| 2019 | -$18.32M | -43.8% |
| 2018 | -$12.74M | — |